MK-5108 (VX-689)

MK-5108 (VX-689) Basic information
Product Name:MK-5108 (VX-689)
Synonyms:MK-5108;trans-4-(3-Chloro-2-fluorophenoxy)-1-[[6-(2-thiazolylamino)-2-pyridinyl]methyl]cyclohexanecarboxylic acid;VX-689;MK-5108(VX-689);(1r,4r)-4-(3-chloro-2-fluorophenoxy)-1-((6-(thiazol-2-ylaMino)pyridin-2-yl)Methyl)cyclohexanecarboxylic acid;MK-5198;MK 5108; VX-689; VX 689; MK5108; VX689;CS-545
CAS:1010085-13-8
MF:C22H21ClFN3O3S
MW:461.94
EINECS:
Product Categories:Inhibitors;Inhibitor
Mol File:1010085-13-8.mol
MK-5108 (VX-689) Structure
MK-5108 (VX-689) Chemical Properties
Boiling point 637.6±65.0 °C(Predicted)
density 1.429
storage temp. under inert gas (nitrogen or Argon) at 2–8 °C
solubility ≥23.1 mg/mL in DMSO; insoluble in EtOH; insoluble in H2O
form solid
pka4.41±0.44(Predicted)
Safety Information
MSDS Information
MK-5108 (VX-689) Usage And Synthesis
UsesMK-5108 is a highly selective Aurora-A kinase inhibitor that shows antitumor activity alone and in combination with Docetaxel (D494420).
DefinitionChEBI: 4-(3-chloro-2-fluorophenoxy)-1-[[6-(2-thiazolylamino)-2-pyridinyl]methyl]-1-cyclohexanecarboxylic acid is an aromatic ether.
Biological Activitymk-5108, also known as vx-689, is a novel, potent and selective inhibitor of aurora a kinase (aak) that competitively binds to the atp binding site of aak and hence potently inhibits the activity of aak with 50% inhibition concentration ic50 value of 0.064 nm. mk-5108 also inhibits other members of aurora kinase family, including aurora b kinase (ic50 = 14 nm) and aurora c kinase (ic50 = 12 nm), with a lesser potency. mk-5108 has been extensively studies and found to exhibit antitumor activity in a wide range of cancer types, including breast, cervix, colorectal, ovary and pancreas neoplasms.myke r. green, bs, pharm.d., bcop, joseph e. woolery, bs, pharm.d, and daruka mahadevan, md, phd. update on aurora kinase targeted therapeutics in oncology. recent pat anticancer drug discov. 2008 november ; 3(3): 162–177.
targetAurora-A
MK-5108 (VX-689) Preparation Products And Raw materials
Barasertib (AZD1152-HQPA) MLN8054 Hesperadin Aurora A Inhibitor I Alisertib (MLN8237) Bortezomib

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.